Co-Diagnostics, Inc. (CODX): Price and Financial Metrics


Co-Diagnostics, Inc. (CODX): $2.90

-0.08 (-2.68%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CODX POWR Grades

  • CODX scores best on the Value dimension, with a Value rank ahead of 98.88% of US stocks.
  • CODX's strongest trending metric is Growth; it's been moving down over the last 177 days.
  • CODX ranks lowest in Growth; there it ranks in the 0th percentile.

CODX Stock Summary

  • The ratio of debt to operating expenses for CO-DIAGNOSTICS INC is higher than it is for about only 5.75% of US stocks.
  • CODX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 10.71% of US stocks.
  • As for revenue growth, note that CODX's revenue has grown -49.14% over the past 12 months; that beats the revenue growth of merely 3.85% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to CO-DIAGNOSTICS INC are LGVN, QUIK, VRAR, VIVE, and AMWL.
  • Visit CODX's SEC page to see the company's official filings. To visit the company's web site, go to www.codiagnostics.com.

CODX Valuation Summary

  • In comparison to the median Healthcare stock, CODX's price/sales ratio is 10% lower, now standing at 1.8.
  • Over the past 66 months, CODX's price/earnings ratio has gone up 40.

Below are key valuation metrics over time for CODX.

Stock Date P/S P/B P/E EV/EBIT
CODX 2022-12-02 1.8 0.7 6.3 0.9
CODX 2022-12-01 1.8 0.7 6.2 0.8
CODX 2022-11-30 1.7 0.7 6.1 0.7
CODX 2022-11-29 1.7 0.7 6.1 0.7
CODX 2022-11-28 1.8 0.7 6.4 0.9
CODX 2022-11-25 1.9 0.8 6.8 1.3

CODX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CODX has a Quality Grade of B, ranking ahead of 88% of graded US stocks.
  • CODX's asset turnover comes in at 1.285 -- ranking 10th of 186 Medical Equipment stocks.
  • ALGN, IART, and XENT are the stocks whose asset turnover ratios are most correlated with CODX.

The table below shows CODX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.285 0.835 2.189
2021-03-31 1.529 0.792 2.398
2020-12-31 1.631 0.777 2.360
2020-09-30 1.671 0.740 2.026
2020-06-30 1.636 0.746 2.230
2020-06-30 1.636 0.654 1.725

CODX Price Target

For more insight on analysts targets of CODX, see our CODX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $22.50 Average Broker Recommendation 1.67 (Moderate Buy)

CODX Stock Price Chart Interactive Chart >

Price chart for CODX

CODX Price/Volume Stats

Current price $2.90 52-week high $10.90
Prev. close $2.98 52-week low $2.76
Day low $2.88 Volume 140,200
Day high $2.99 Avg. volume 440,022
50-day MA $3.31 Dividend yield N/A
200-day MA $4.66 Market Cap 89.66M

Co-Diagnostics, Inc. (CODX) Company Bio


Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.


CODX Latest News Stream


Event/Time News Detail
Loading, please wait...

CODX Latest Social Stream


Loading social stream, please wait...

View Full CODX Social Stream

Latest CODX News From Around the Web

Below are the latest news stories about CO-DIAGNOSTICS INC that investors may wish to consider to help them evaluate CODX as an investment opportunity.

Co-Diagnostics, Inc. (NASDAQ:CODX) Analysts Are More Bearish Than They Used To Be

Market forces rained on the parade of Co-Diagnostics, Inc. ( NASDAQ:CODX ) shareholders today, when the analysts...

Yahoo | December 3, 2022

Co-Diagnostics, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference on December 1, 2022

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be presenting on December 1, 2022, at the Piper Sandler 34th Annual Healthcare Conference, held November 29-December 31, 2022, in New York City, New York.

Yahoo | November 30, 2022

Co-Diagnostics Third Quarter 2022 Earnings: Misses Expectations

Co-Diagnostics ( NASDAQ:CODX ) Third Quarter 2022 Results Key Financial Results Revenue: US$5.09m (down 83% from 3Q...

Yahoo | November 16, 2022

Co-Diagnostics, Inc. to Host Booth at MEDICA 2022 Trade Fair in Düsseldorf, Germany

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth this week at the MEDICA 2022 trade fair in Düsseldorf, Germany from 15-17 November.

Yahoo | November 14, 2022

Co-Diagnostics, Inc.'s (NASDAQ:CODX) Intrinsic Value Is Potentially 23% Below Its Share Price

In this article we are going to estimate the intrinsic value of Co-Diagnostics, Inc. ( NASDAQ:CODX ) by estimating the...

Yahoo | November 12, 2022

Read More 'CODX' Stories Here

CODX Price Returns

1-mo -18.99%
3-mo -10.49%
6-mo -42.91%
1-year -66.12%
3-year 192.93%
5-year -34.09%
YTD -67.53%
2021 -3.98%
2020 938.87%
2019 -39.92%
2018 -43.56%
2017 N/A

Continue Researching CODX

Want to see what other sources are saying about Co-Diagnostics Inc's financials and stock price? Try the links below:

Co-Diagnostics Inc (CODX) Stock Price | Nasdaq
Co-Diagnostics Inc (CODX) Stock Quote, History and News - Yahoo Finance
Co-Diagnostics Inc (CODX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7686 seconds.